The health-care sector ETF came within a cent of its 52-week high, led by Eli Lilly, while the Russell 2000 outpaced the Nasdaq-100 by about 1.6 points and the VIX fell nearly 6%. The split between defensive leadership and risky small caps makes Tuesday hard to read as a single trade.
Tuesday's stock market was led by two groups that usually lead on different kinds of days.
The S&P 500's health-care sector reached an all-time high during the session, Reuters reported. The Health Care Select Sector SPDR Fund, a widely traded proxy, was up 2.3% at $179.73 at about 2 p.m. Eastern, after reaching $180.06, a cent below its own 52-week high. Eli Lilly rose 4.2% to $1,292.68 after touching $1,311.75, a record. Amgen, Pfizer, Johnson & Johnson and AbbVie each rose more than 2% earlier in the session.
At the same time, the iShares Russell 2000 ETF was up 1.7%. The Invesco QQQ Trust, which tracks the Nasdaq-100, rose just 0.1%. Financial stocks gained 1.2%, and the Cboe Volatility Index fell 5.7% to 17.39.
The defensive story
Health care has been the market's refuge since the hot September consumer price report on Oct. 14. As investors sold technology and semiconductor shares on doubts about spending on artificial intelligence, they bought large drugmakers with steadier earnings. The health-care fund set a record on Oct. 15 in the middle of that selling.
Tuesday's move fits that pattern, but it also had company-specific help. Goldman Sachs raised its Lilly price target to $1,413 from $1,371, a day after Bank of America raised its target to $1,397. Because Lilly is one of the largest weights in the sector fund, a single-stock rally can carry much of a sector move on its own.
The risk-on story
Small caps tell a different story. The Russell 2000 is weighted toward smaller companies, many of which borrow at floating rates and depend on the domestic economy. They do well when yields fall and growth expectations hold up, not when investors are seeking shelter. Tuesday's 1.7% gain came as the 10-year Treasury yield fell to a session low of 5.075% and oil dropped as much as about $6 a barrel from its high on reports of a mediation proposal in the Iran conflict. A falling VIX also argues against a flight to safety: frightened investors buy protection, and protection got cheaper.
One session, two trades
The simplest way to reconcile the two is that they are separate trades. Money is rotating out of the most expensive AI-linked stocks and into health care as a slow-moving trend, while small caps and financials are responding to a single day's drop in yields and oil. The Nasdaq-100's flat performance is the common thread: whatever investors were buying, it was not the market's largest technology names.
Market implications
One reading is that this is a defensive rotation with a lift from lower yields. Health-care leadership extends a trend that began with the inflation scare, and the small-cap gain will fade if yields resume their rise.
A second reading is that the rally is broadening. Small caps, financials and health care all outperforming a flat Nasdaq-100 is what a market looks like when it stops depending on a handful of technology stocks, and a falling VIX supports that.
Breadth over the next few sessions will decide it. If small caps hold their gains when yields stop falling, the broadening reading gains weight.
What to watch
Results from Meta and Tesla after Wednesday's close, which will test whether technology can regain leadership; the 10-year yield; Lilly's trading after two target raises; small-cap performance on the next day yields rise; and the Fed's decision on Oct. 28. A health-care rally that continues while small caps fall back would confirm the defensive reading.